ONYX PHARMACEUTICALS INC Accounts Receivable
ONYX PHARMACEUTICALS INC had Accounts Receivable of $131.31 million as of 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2013-08-09
- 2013-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $131.31M.
- 2013-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $132.64M.
- 2012-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $79.12M.
- 2012-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $25.45M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2013-06-30 | $131.31M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $132.64M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $79.12M 10-Q · filed 2013-08-09 |
| 2012-09-30 | $25.45M 10-Q · filed 2012-11-02 |